Drug intelligence / Profile preview

flavin adenine dinucleotide

Development stage
Unknown
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral, Ophthalmic, Topical
01

Overview

Flavin adenine dinucleotide (FAD) is a redox-active coenzyme form of vitamin B2 (riboflavin). It is a condensation product of riboflavin and adenosine diphosphate. FAD functions as an essential cofactor for various aerobic dehydrogenases and oxidoreductases—collectively known as flavoenzymes or flavoproteins—which are involved in electron transfer reactions in cellular metabolism. Clinically, FAD is used to treat conditions associated with vitamin B2 deficiency such as keratitis, blepharitis, stomatitis, eczema, and metabolic disorders. It is approved for use in Japan under the trade names Adeflavin and Flavitan for ophthalmic indications related to vitamin B2 deficiency[1][3][4][5]. FAD acts primarily by serving as an electron carrier within the mitochondrial respiratory chain and other metabolic pathways. Many oxidoreductase enzymes require FAD as a prosthetic group for their activity[1][4]. No significant adverse reactions have been reported.

Brand names
EnBrace HREnLyteAdeflavinFlavitan
Other names
FADflavin-adenine dinucleotide

Beyond the preview

Go deeper on flavin adenine dinucleotide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on flavin adenine dinucleotide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call